About: Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33 that has completed Phase 1 clinical studies; and Crebankitug (ZB-168), a fully human immunoglobulin G1 monoclonal antibody targeting interleukin-7 receptor alpha that has completed Phase 1 clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.35 (+1.87%)
ZURA NASDAQ Zura Bio Limited Class A Ordinary Shares
Zura Bio Limited Class A Ordinary Shares share price
Atividade de preço de ZURA
Último preço
$ 4,350
Variação (24h)
0,08 USD (1,87%)
Volume
4.38M
Volume (média 4 sem.)
-
Abertura
$ 4,23
Variação do dia
$ 4,11 - $ 4,60
Fechamento anterior
$ 4,27
Último negócio
28 Oct, 8:23 pm GMT+0
Atrasado
28 Oct, 8:23 pm GMT+0
ZURA price performance
Atrasado
28 Oct, 8:23 pm GMT+0
quote.marketSignals